Kymera Therapeutics Stock: A First Take (NASDAQ:KYMR)

Kymera Therapeutics Stock: A First Take (NASDAQ:KYMR)
Kymera Therapeutics Stock: A First Take (NASDAQ:KYMR)

Kymera Therapeutics has one asset undergoing evaluation in a Phase 1 study and another two molecules about ready to enter the clinic. Read more about KYMR here.